Skip to main content

The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics

Abstract

Helicobacter pylori-associated infections are extremely common in Iran, but few data about antibiotic sensitivity of H. pylori are available for this region. The purpose of this study was to investigate the prevalence of resistance in isolates against commonly used antibiotics in Eastern Azerbaijan, Iran, and the dependence of prevalence on the sex and age of patients. H. pylori isolates were collected by culture from gastric biopsies. Antibiotic susceptibility of isolates was determined by use of the disk agar diffusion test, and the minimum inhibitory concentration of clarithromycin was established by use of the Etest. A total 395 of biopsy specimens were studied; 112 samples of H. pylori were isolated (28.3 %), 55 (49 %) from males and 57 (51 %) from females. The prevalence of resistance to clarithromycin, metronidazole, erythromycin, amoxicillin, ciprofloxacin, rifampin, nitrofurantoin, and tetracycline were 16 (14.3 %), 86 (76.8 %), 29 (26.0 %), 32 (28.6 %), 37 (33.0 %), 32 (28.6 %), 13 (11.6 %), and 21 (18.7 %), respectively. Antimicrobial resistance was not statistically significantly associated with sex or age. Furthermore, the prevalence of resistance to metronidazole was high and that to clarithromycin was reasonable, consistent with reported low success in H. pylori treatment in this area. Therefore, continuous surveillance of antibiotic resistance of H. pylori is essential.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. López-Brea M, Martínez MJ, Domingo D, Alarcón T. A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. J Antimicrob Chemother. 2001;48:295.

    PubMed  Article  Google Scholar 

  2. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol. 1995;7:427.

    PubMed  CAS  Google Scholar 

  3. Yakoob J, Fan X, Hu G, Liu L, Zhang Z. Antibiotic susceptibility of Helicobacter pylori in the Chinese population. J gastroenterol Hepatol. 2001;16:981–5.

    PubMed  Article  CAS  Google Scholar 

  4. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther. 1997;11:43–53.

    PubMed  Article  CAS  Google Scholar 

  5. Alarcón T, Domingo D, López-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents. 1999;12:19–26.

    PubMed  Article  Google Scholar 

  6. McNulty C, Owen R, Tompkins D, Hawtin P, McColl K, Price A, et al. Helicobacter pylori susceptibility testing by disc diffusion. J Antimicrob Chemother. 2002;49:601.

    PubMed  Article  CAS  Google Scholar 

  7. Boyanova L, Stancheva I, Spassova Z, Katzarov N, Mitov I, Koumanova R. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. J Med Microbiol. 2000;49:415–8.

    PubMed  CAS  Google Scholar 

  8. Mishra KK, Srivastava S, Garg A, Ayyagari A. Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and Etest methods. Curr Microbiol. 2006;53:329–34.

    PubMed  Article  CAS  Google Scholar 

  9. Clinical, laboratory standards I. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18. PA: CLSI Wayne; 2008.

  10. Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the Etest for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol. 1991;29:2072.

    PubMed  CAS  Google Scholar 

  11. O’Connor A, Taneike I, Nami A, Fitzgerald N, Murphy P, Ryan B, et al. Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland. Eur J Gastroenterol Hepatol. 2010;22:1123.

    PubMed  Article  Google Scholar 

  12. Selgrad M, Bornschein J, Malfertheiner P. Guidelines for treatment of Helicobacter pylori in the East and West. Expert Rev Anti-infect Ther. 2011;9:581–8.

    PubMed  Article  Google Scholar 

  13. Chey WD, Wong BCY. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808–25.

    PubMed  Article  CAS  Google Scholar 

  14. De Francesco V, Margiotta M, Zullo A, Hassan C, Troiani L, Burattini O, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med. 2006;144:94–100.

    PubMed  Google Scholar 

  15. Mohammadi M, Doroud D, Mohajerani N, Massarrat S. Helicobacter pylori antibiotic resistance in Iran. World J Gastroenterol. 2005;11:6009.

    PubMed  CAS  Google Scholar 

  16. Rafeey M, Ghotaslou R, Nikvash S, Ashrafy Hafez A. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother. 2007;13:291–5.

    Google Scholar 

  17. Siavashi F, Safari F, Doratotaj D, Khatami GHR, Falahi GHH, Mirnaseri SMM. Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children. Arch Iran Med. 2006;9:308–14.

    Google Scholar 

  18. Nariman F, Eftekhar F, Habibi Z, Falsafi T. Anti‐Helicobacter pylori activities of six Iranian plants. Helicobacter. 2004;9:146–51.

    PubMed  Article  Google Scholar 

  19. Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol. 2004;42:387–9.

    PubMed  Article  CAS  Google Scholar 

  20. Talebi Bezmin Abadi A, Mobarez AM, Taghvaei T, Wolfram L. Antibiotic Resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter. 2010;15:505–9.

    PubMed  Article  Google Scholar 

  21. McMahon BJ, Hennessy TW, Bensler JM, Bruden DL, Parkinson AJ, Morris JM, et al. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med. 2003;139:463–9.

    PubMed  Google Scholar 

  22. Pilotto A, Rassu M, Leandro G, Franceschi M, Di Mario F. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. Dig Liver Dis. 2000;32:763–8.

    PubMed  Article  CAS  Google Scholar 

  23. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis. 2004;10:1088–94.

    PubMed  Article  Google Scholar 

  24. Kohanteb J, Bazargani A, Saberi-Firoozi M, Mobasser A. Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in Shiraz-Iran. Indian J Med Microbiol. 2007;25:374.

    PubMed  Article  CAS  Google Scholar 

  25. Megraud F. Helicobacter pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut. 2004;53:1374.

    PubMed  Article  CAS  Google Scholar 

  26. Camorlinga-Ponce M, Perez–Perez G, Madrazo-De la Garza A, Dehesa M, Gonzalez-Valencia G, et al. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol. 2001;39:2677.

    PubMed  Article  Google Scholar 

  27. Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M. Comparative evaluation of the Etest, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol. 1997;35:1842.

    PubMed  CAS  Google Scholar 

  28. Egan BJ, Katicic M, O’Connor HJ, O’Morain CA. Treatment of Helicobacter pylori. Helicobacter. 2007;12:31–7.

    PubMed  Article  CAS  Google Scholar 

  29. Grignon B, Tankovic J, Megraud F, Glupczynski Y, Husson MO, Conroy MC, et al. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist. 2002;8:61–6.

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This project was financially supported by the Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. This article was based on a data from a PhD thesis registered in Tabriz University of Medical Sciences.

Ethical standards

This paper has been approved by the regional Medical Research Ethics Committee of Tabriz University of Medical Sciences, number: 5/4/9591.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reza Ghotaslou.

About this article

Cite this article

Milani, M., Ghotaslou, R., Akhi, M.T. et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. J Infect Chemother 18, 848–852 (2012). https://doi.org/10.1007/s10156-012-0425-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-012-0425-4

Keywords

  • Antimicrobial resistance
  • Clarithromycin
  • H. pylori
  • Metronidazole